Imaging Granzyme B Activity Assesses Immune-Mediated Myocarditis

被引:31
|
作者
Konishi, Masanori [1 ,3 ]
Erdem, S. Sibel [4 ,5 ]
Weissleder, Ralph [4 ]
Lichtman, Andrew H. [2 ]
McCarthy, Jason R. [4 ]
Libby, Peter [1 ,3 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pathol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02115 USA
[5] Istanbul Medipol Univ, Int Sch Med, Istanbul, Turkey
基金
日本学术振兴会; 美国国家卫生研究院;
关键词
dexamethasone; granzyme; immunology; molecular imaging; myocarditis; CARDIOVASCULAR MAGNETIC-RESONANCE; DIFFERENTIATION;
D O I
10.1161/CIRCRESAHA.115.306364
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: The development of molecular imaging approaches that assess specific immunopathologic mechanisms can advance the study of myocarditis. Objective: This study validates a novel molecular imaging tool that enables the in vivo visualization of granzyme B activity, a major effector of cytotoxic CD8(+) T lymphocytes. Methods and Results: We synthesized and optimized a fluorogenic substrate capable of reporting on granzyme B activity and examined its specificity ex vivo in mice hearts with experimental cytotoxic CD8(+) T lymphocyte-mediated myocarditis using fluorescence reflectance imaging, validated by histological examination. In vivo experiments localized granzyme B activity in hearts with acute myocarditis monitored by fluorescent molecular tomography in conjunction with coregistered computed tomography imaging. A model anti-inflammatory intervention (dexamethasone administration) in vivo reduced granzyme B activity (vehicle versus dexamethasone: 504263 versus 194 +/- 77 fluorescence intensities in hearts; P=0.002). Conclusions: Molecular imaging of granzyme B activity can visualize T cell-mediated myocardial injury and monitor the response to an anti-inflammatory intervention.
引用
收藏
页码:502 / 512
页数:11
相关论文
共 50 条
  • [1] Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management
    Caforio, Alida L. P.
    Marcolongo, Renzo
    Jahns, Roland
    Fu, Michael
    Felix, Stephan B.
    Iliceto, S.
    HEART FAILURE REVIEWS, 2013, 18 (06) : 715 - 732
  • [2] Immune-Mediated Myocarditis in Fabry Disease Cardiomyopathy
    Frustaci, Andrea
    Verardo, Romina
    Grande, Claudia
    Galea, Nicola
    Piselli, Pierluca
    Carbone, Iacopo
    Alfarano, Maria
    Russo, Matteo Antonio
    Chimenti, Cristina
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (17):
  • [3] Management of Ventricular Arrhythmias in Immune-Mediated Myocarditis
    Narasimhan, C.
    Subramanian, Muthiah
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2020, 6 (10) : 1235 - 1237
  • [4] Immunomodulating and Immunosuppressive Therapy for Virus-Negative Immune-Mediated Myocarditis
    Frustaci, Andrea
    Letizia, Claudio
    Alfarano, Maria
    Marchionni, Giulia
    Verardo, Romina
    Chimenti, Cristina
    BIOMEDICINES, 2024, 12 (07)
  • [5] Role of T Cells in Viral and Immune-mediated Myocarditis
    Cheng, Chunyan
    Baritussio, Anna
    Giordani, Andrea Silvio
    Marcolongo, Renzo
    Caforio, Alida L. P.
    Iliceto, Sabino
    CARDIOLOGY DISCOVERY, 2024, 4 (01): : 43 - 54
  • [6] Tofacitinib for treatment in immune-mediated myocarditis: The first reported cases
    Liu, Yun
    Jiang, Lindi
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (03) : 739 - 746
  • [7] Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management
    Alida L. P. Caforio
    Renzo Marcolongo
    Roland Jahns
    Michael Fu
    Stephan B. Felix
    S. Iliceto
    Heart Failure Reviews, 2013, 18 : 715 - 732
  • [8] Myocarditis in systemic immune-mediated diseases: Prevalence, characteristics and prognosis. A systematic review
    Cheng, Chun-Yan
    Baritussio, Anna
    Giordani, Andrea Silvio
    Iliceto, Sabino
    Marcolongo, Renzo
    Caforio, Alida L. P.
    AUTOIMMUNITY REVIEWS, 2022, 21 (04)
  • [9] STAT3 activity is necessary and sufficient for the development of immune-mediated myocarditis in mice and promotes progression to dilated cardiomyopathy
    Camporeale, Annalisa
    Marino, Francesca
    Papageorgiou, Anna
    Carai, Paolo
    Fornero, Sara
    Fletcher, Steven
    Page, Brent D. G.
    Gunning, Patrick
    Forni, Marco
    Chiarle, Roberto
    Morello, Mara
    Jensen, Ole
    Levi, Renzo
    Heymans, Stephane
    Poli, Valeria
    EMBO MOLECULAR MEDICINE, 2013, 5 (04) : 572 - 590
  • [10] A closer look at immune-mediated myocarditis in the era of combined checkpoint blockade and targeted therapies
    Guo, Christina W.
    Alexander, Marliese
    Dib, Youseph
    Lau, Peter K. H.
    Weppler, Alison M.
    Au-Yeung, George
    Lee, Belinda
    Khoo, Chloe
    Mooney, Don
    Joshi, Subodh B.
    Creati, Louise
    Sandhu, Shahneen
    EUROPEAN JOURNAL OF CANCER, 2020, 124 : 15 - 24